StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) stock

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.80−0.14 (-6.96%)

Close on Nov 18, 2026Market cap $144.72MP/E –Yield –

BridgeBio Oncology Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BridgeBio Oncology Therapeutics's shares outstanding was 80M at Jun 30, 2026. For fiscal 2025 it was 31M, up 241276.2% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202531M+241276.2%
FY2024Dec 31, 20240M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202680M+19582.7%
Q1 FY2026Mar 31, 20260M+336.3%
Q3 FY2025Sep 30, 202543M+392100.2%
Q2 FY2025Jun 30, 202550M–
Q1 FY2025Mar 31, 20250M–
Q4 FY2024Dec 31, 20240M–
Q3 FY2024Sep 30, 20240M–

More BridgeBio Oncology Therapeutics figures

See a number that looks wrong?